This workshop summary has been reviewed in draft form by persons chosen for their diverse perspectives and technical expertise in accordance with procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the institution in making the published workshop summary as sound as possible and to ensure that it meets institutional standards of objectivity, evidence, and responsiveness to the charge. The review comments and draft manuscript remain confidential to protect the integrity of the deliberative process. We wish to thank the following individuals for their review of this summary:
- Carole Bewley, National Institute of Diabetes and Digestive and Kidney Diseases
- Nicole Mahoney, The Pew Charitable Trusts
- Melinda Moore, RAND Corporation
- Douglas Weibel, University of Wisconsin, Madison
Although the reviewers listed above provided many constructive comments and suggestions, they did not see the final draft of the workshop summary before its release. The review of this summary was overseen by Douglas Lauffenburger, Massachusetts Institute of Technology. Appointed by the National Research Council, he was responsible for making certain that an independent examination of this workshop summary was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the final content of this workshop summary rests entirely with the authors and the institution.
National Academies Press (US), Washington (DC)
Chemical Sciences Roundtable; Board on Chemical Sciences and Technology; Division on Earth and Life Studies; National Research Council. Technological Challenges in Antibiotic Discovery and Development: A Workshop Summary. Washington (DC): National Academies Press (US); 2014 Jan 27. Acknowledgment of Reviewers.